By targeting underlying synovitis, the novel intra-articular liraglutide formulation 4P004 aims to bridge the gap between transient symptom relief and disease modification in knee OA.

Ongoing research led by Professor Martyn Snow, a Consultant Orthopaedic Surgeon at The Robert Jones and Agnes Hunt Orthopaedic Hospital in Oswestry, Shropshire, explores how Arthrosamid (R) could ...

The Phase 2b trial has been designed to be statistically powered to evaluate key efficacy endpoints, including change from baseline in pain and physical function compared with placebo, measured at ...

Background: Osteoarthritis of the knee affects up to 10% of the elderly population. The condition is frequently treated by intra-articular injection of hyaluronic acid. We performed a systematic ...

Injections duplicate most OA features in mice ...

We recently compiled a list of the 8 Oversold Biotech Stocks to Invest In Now. Enlivex Ltd. is one of the oversold stocksto ...

Click here to read the Cover Story, “More treatments expand personalized ankle cartilage repair.”A middle-aged, active patient — the kind who alternates between running along the canals and cycling ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report ...

Total Knee Replacement Market OverviewThe global total knee replacement (TKR) market is projected to witness steady growth over the next five years with an estimated growth rate of around 5%. The ...

A single shot into a damaged joint reversed osteoarthritis in animals within weeks, according to researchers at the ...

Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following ...

Accelerated federal project, combining expertise from CU Anschutz, CU Boulder and Colorado State University scientists, aims ...